Together, these data imply that Sph and, in particular, S1P production may significantly contribute to colon cancer development and that the enzymatic pathways responsible for their formation could be targeted by enzyme-specific therapeutic approaches. This evidence concerns the gene MBTPS1 and colonic neoplasm.